CD276 and hepatocellular carcinoma: Even though it is still uncertain whether B7-H3 plays a direct role in inhibiting T-cell function [23], our study revealed majority of sHCC patients had B7-H3-expressing tumor cells in both sarcomatoid and conventional HCC components.